Maturation and Characterization of Smooth Muscle Cells from Human Embryonic Stem Cells
Author Information
Author(s): Vazão Helena, Neves Ricardo Pires das, Grãos Mário, Ferreira Lino
Primary Institution: CNC - Center of Neurosciences and Cell Biology, University of Coimbra, Coimbra, Portugal
Hypothesis
CD34+ cells derived from human embryonic stem cells have higher smooth muscle cell potential than CD34− cells.
Conclusion
The study demonstrates that hESC-derived smooth muscle cells can be effectively differentiated and characterized for potential use in tissue engineering.
Supporting Evidence
- CD34+ cells have higher smooth muscle cell potential than CD34− cells.
- Retinoic acid and platelet-derived growth factor are effective in guiding differentiation.
- SMPCs can contract in response to vasoactive agents.
- 3D culture enhances the expression of smooth muscle cell markers.
- Co-culture with hVSMCs improves the organization of contractile proteins.
Takeaway
Scientists found that certain cells from human embryos can turn into muscle cells that help blood vessels work better, which could help in making new blood vessels for sick people.
Methodology
The study involved isolating CD34+ and CD34− cells from human embryoid bodies and culturing them with various inductive signals to evaluate their differentiation into smooth muscle progenitor cells.
Limitations
The study does not fully explore the long-term functionality and integration of the differentiated cells in vivo.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website